Long-term protective potency of AAV vector-based SARS-CoV-2 prophylaxis in mice and non-human primates - Quiz - MDSpire

Long-term protective potency of AAV vector-based SARS-CoV-2 prophylaxis in mice and non-human primates

  • By

  • Ekaterina I. Ryabova

  • Artem A. Derkaev

  • Ilias B. Esmagambetov

  • Mikhail A. Dovgiy

  • Ilya V. Gordeychuk

  • Inna V. Shuliakova

  • Rosa M. Hossain

  • Anton A. Blinov

  • Anna A. Iliukhina

  • Daria M. Grousova

  • Ilya D. Zorkov

  • Daria V. Avdoshina

  • Stanislav A. Gulyaev

  • Vasiliy D. Apolokhov

  • Tatiana V. Gulyaeva

  • Irina A. Favorskaya

  • Dmitry V. Shcheblyakov

  • Alexander L. Gintsburg

  • Denis Y. Logunov

  • June 4, 2026

  • 0 min

Share

Original Source(s)

Long-term protective potency of AAV vector-based SARS-CoV-2 prophylaxis in mice and non-human primates

  • by Ekaterina I. Ryabova, Artem A. Derkaev, Ilias B. Esmagambetov, Mikhail A. Dovgiy, Ilya V. Gordeychuk, Inna V. Shuliakova, Rosa M. Hossain, Anton A. Blinov, Anna A. Iliukhina, Daria M. Grousova, Ilya D. Zorkov, Daria V. Avdoshina, Stanislav A. Gulyaev, Vasiliy D. Apolokhov, Tatiana V. Gulyaeva, Irina A. Favorskaya, Dmitry V. Shcheblyakov, Alexander L. Gintsburg, Denis Y. Logunov

  • June 4, 2026

Related Content

Commentary: The effects of postponing BCG vaccination on the risk of BCG-related complications among patients with severe combined immunodeficiency disease in Saudi Arabia

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.

Acute liver failure and secondary TMA-like phenomenon following SARS-CoV-2 and Mycoplasma pneumoniae co-detection in a child: a case report